An independent, external validation study of proposed genetic biomarkers of irinotecan toxicity and pharmacokinetics.
F. Innocenti
No relevant relationships to disclose
G. L. Rosner
Stock Ownership - Pfizer (B)
W. Qiao
No relevant relationships to disclose
A. M. de Graan
No relevant relationships to disclose
M. J. Ratain
Consultant or Advisory Role - Drais Pharmaceuticals; Mersana
Other Remuneration - University of Chicago
R. H. N. van Schaik
No relevant relationships to disclose
J. Ramirez
No relevant relationships to disclose
R. Mathijssen
No relevant relationships to disclose